Covid-19 vaccine rollout will be significant both as a recipient of the medicine as well as a producer, according to Fitch Solutions Country Risk and Industry Research.The country has one of the largest vaccine manufacturing capacities in the world (including the largest vaccine producer - Serum Institute India) and has secured authorisation to mass-produce the AstraZeneca, Novavax, and Gamaleya Research Institute vaccines.Also Read | Inside the rumble in India’s coding jungleWith a population of 1.3 billion (and 94 million over 65-year-olds), the domestic vaccination drive will be the largest in the world, said Fitch.The country has a good track record of such drives with masses of the population regularly gaining inoculation for various.